Publicacións en colaboración con investigadores/as de Corporació Sanitària Parc Taulí (2)

2019

  1. Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 7, pp. 2277-2283.e2

2011

  1. Effects of omalizumab in Aspergillus-associated airway disease

    Thorax